Vulnerabilities in Anonymous Credential Systems

We show the following:

(i) In existing anonymous credential revocation systems, the revocation authority can link the transactions of any user in a subset T of users in O(log|T|) fake failed sessions.

(ii) A concern about the DLREP-I anonymous credentials system described in [Stefan Brands: Rethinking public key infrastructure and Digital Certificates; The MIT Press, Cambridge Massachusetts, London England. ISBN 0-262-02491-8] and [Stefan Brands: A Technical Overview of Digital Credentials; February 2002 (was a white paper in credentica.com)].

Failure of Titanium Condenser Tubes After 24 Years Power Plant Service

The titanium condenser has been in operation for 24 years at Amager unit 3 power plant. In February 2012, the plant was contaminated by seawater due to a failed condenser tube and some tubes were plugged. A month later, the plant tripped again. Small leaks were found again and finally approx. 200 tubes were plugged before the condenser was in service again. A series of inspections, NDT, and destructive examinations were conducted to try and understand the cause of failure in the tubes within the condenser. After such investigations, degradation mechanisms such as inner fouling, steam impingement, and fretting/erosion around the supports could be discounted. Ductile cracks were found in the tube within the tubesheet. From circumstantial evidence, it was concluded that failure was caused by a semi-filled condenser which led to a mismatch in expansion coefficients of filled tubes and unfilled tubes during a plant trip. In addition, small amounts of titanium hydride were revealed to be present in the tubes within the tubesheet indicating that the carbon steel tubesheet was corroding due to ingress of salt water. Although this was not the reason for the failure, it indicated the need for repair of the epoxy coating in the waterbox.     

Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma

Neurons are especially susceptible to oxidative damage, which is increasingly implicated in neurodegenerative disease. Certain N‐acylethanolamines (NAEs) have been shown to protect neurons from oxidative stress. Since glaucoma may be considered a neurodegenerative disorder and the survival of retinal neurons could also be influenced by N‐acylethanolamines, our goal was to quantify changes in certain N‐acylethanolamine species and their oxylipin derivatives in the retina of a mouse model for glaucoma. We also sought to identify relationships between these and parameters of glaucoma disease development, specifically intraocular pressure, visual acuity, and contrast sensitivity. Five N‐acylethanolamine species and three NAE oxylipin derivatives were quantified in retina from young and aged DBA/2Crl mice. N‐Acylethanolamines and NAE‐oxylipins in retinal extracts were quantified against deuterated standards by isotope dilution gas chromatography–mass spectrometry. Levels (nmol/g dry weight) of N‐arachidonoylethanolamine (anandamide; NAE 20:4) were significantly (p = 0.008) decreased in aged (2.875 ± 0.6702) compared to young animals (5.175 ± 0.971). Conversely, the anandamide oxylipin, 15(S)‐HETE ethanolamide (15(S)‐HETE EA), was significantly (p = 0.042) increased in aged (0.063 ± 0.009) compared to young animals (0.039 ± 0.011). Enzymatic depletion of the anandamide pool by 15‐lipoxygenase and consequent accumulation of 15(S)‐HETE ethanolamine may contribute to decreased visual function in glaucomatous mice. Since N‐acylethanolamines effectively attenuate glaucoma pathogenesis and associated visual impairment, our data provides additional rationale and novel targets for glaucoma therapies.     

Efficient shift detection using multivariate exponentially-weighted moving average control charts and principal components

This paper demonstrates the use of principal components in conjunction with the multivariate exponentially-weighted moving average (MEWMA) control procedure for process monitoring. It is demonstrated that the number of variables to be monitored is reduced through this approach, and that the average run length to detect process shifts or upsets is substantially reduced as well. The performance of the MEWMA applied to all the variables may be related to the MEWMA control chart that uses principal components through the non-centrality parameter. An average run length table demonstrates the advantages of the principal components MEWMA over the procedure that uses all of the variables. An illustrative example is provided.     

Short-run statistical process control: Q-Chart enhancements and alternative methods

The first two tables in Reference 1 are incorrect. Corrected tables are provided below. The errors do not affect the conclusions or the discussion in that paper.     

In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells

SMYD3 is a lysine methyltransferase that regulates the expression of over 80 genes and is required for the uncontrolled proliferation of most breast, colorectal, and hepatocellular carcinomas. The elimination of SMYD3 restores normal expression patterns of these genes and halts aberrant cell proliferation, making it a promising target for small molecule inhibition. In this study, we sought to establish a proof of concept for our in silico/in vitro hit-to-lead enzyme inhibitor development platform and to identify a lead small molecule candidate for SMYD3 inhibition. We used Schrodinger^® software to screen libraries of small molecules in silico and the five compounds with the greatest predicted binding affinity within the SMYD3 binding pocket were purchased and assessed in vitro in direct binding assays and in breast cancer cell lines. We have confirmed the ability of one of these inhibitors, Inhibitor-4, to restore normal rates of cell proliferation, arrest the cell cycle, and induce apoptosis in breast cancer cells without affecting wildtype cell behavior. Our results provide a proof of concept for this fast and affordable small molecule hit-to-lead methodology as well as a promising candidate small molecule SMYD3 inhibitor for the treatment of human cancer.